Mesalamine Capsule, Extended Release
Product Images NDC 59651-397

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 59651-397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (0.375 g (120 Capsules Bottle))

Each capsule contains 0.375g of Mesalamine USP and is intended for extended-release. The package insert should be reviewed for prescribing information. The product should be stored in a container at controlled room temperature and protected from light. This medication should be kept out of reach of children. The capsules are manufactured in India and distributed by Aurobindo Pharma USA, Inc. The code AP/DRUGS/04/2016 is associated with this product.*

FDA Label Image

Structure (Mesalamine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.